Medpace Holdings, Inc. Unamortized Debt Issuance Expense
Medpace Holdings, Inc. (MEDP) had Unamortized Debt Issuance Expense of $473.00 thousand as of 2018-09-30, per its 10-Q filed 2018-10-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2018-10-30
- 2018-09-30: Unamortized Debt Issuance Expense $473.00K.
- 2018-06-30: Unamortized Debt Issuance Expense $518.00K.
- 2018-03-31: Unamortized Debt Issuance Expense $566.00K.
- 2017-12-31: Unamortized Debt Issuance Expense $615.00K.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2018-09-30 | $473.00K 10-Q · filed 2018-10-30 |
| 2018-06-30 | $518.00K 10-Q · filed 2018-07-31 |
| 2018-03-31 | $566.00K 10-Q · filed 2018-05-01 |
| 2017-12-31 | $615.00K 10-Q · filed 2018-10-30 |
| 2017-09-30 | $666.00K 10-Q · filed 2017-10-31 |
| 2017-06-30 | $718.00K 10-Q · filed 2017-08-01 |
| 2017-03-31 | $770.00K 10-Q · filed 2017-05-02 |
| 2016-12-31 | $824.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $8.69M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $10.13M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |